Skip to main content
Top

Current Treatment Options in Oncology

Issue 2/2020

Content (8 Articles)

Nausea Palliative and Supportive Care (MP Davis, Section Editor)

Nausea and Vomiting in Advanced Cancer

Rudolph M. Navari

Care Palliative and Supportive Care (MP Davis, Section Editor)

How Effective Is Palliative Care in Improving Patient Outcomes?

Sarah Milazzo, Eric Hansen, Desi Carozza, Amy A. Case

Care Palliative and Supportive Care (MP Davis, Section Editor)

Patient Spirituality as a Component of Supportive Care: Assessment and Intervention

Karina D’Souza, Alan B. Astrow

Cancer Fatigue Palliative and Supportive Care (MP Davis, Section Editor)

Cancer-Related Fatigue: Causes and Current Treatment Options

Melissa S.Y. Thong, Cornelis J. F. van Noorden, Karen Steindorf, Volker Arndt

Melanoma Skin Cancer (T Ito, Section Editor)

Neoadjuvant Immunotherapy for Locally Advanced Melanoma

Meredith S. Pelster, Rodabe N. Amaria

Soft Tissue Sarcoma Sarcoma (SH Okuno, Section Editor)

Extremity Soft Tissue Sarcoma: Role of Local Control

Elyse J. Brinkmann, Safia K. Ahmed, Matthew T. Houdek

Liposarcoma Sarcoma (SH Okuno, Section Editor)

Dedifferentiated Liposarcoma: Systemic Therapy Options

Zhubin Gahvari, Amanda Parkes

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine